FDAnews
www.fdanews.com/articles/146036-fda-completes-inspection-of-cambrex-api-manufacturing-facility

FDA Completes Inspection of Cambrex API Manufacturing Facility

May 1, 2012
The FDA has completed an inspection of Cambrex’s active pharmaceutical ingredient (API) manufacturing facility in Charles City, Iowa. The inspectors, who visited the facility in February 2012, found that the site is compliant with the principles and guidelines of good manufacturing process.
Pharmaceutical Business Review